| 68Ga-PSMA-PET/CT in patients with biochemical prostate cancer recurrence and negative 18F-choline-PET/CT C Bluemel, M Krebs, B Polat, F Linke, M Eiber, S Samnick, C Lapa, ... Clinical nuclear medicine 41 (7), 515-521, 2016 | 219 | 2016 |
| Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy K Herrmann, C Bluemel, M Weineisen, M Schottelius, HJ Wester, ... Journal of Nuclear Medicine 56 (6), 855-861, 2015 | 171 | 2015 |
| Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 … B Kneitz, M Krebs, C Kalogirou, M Schubert, S Joniau, H van Poppel, ... Cancer research 74 (9), 2591-2603, 2014 | 149 | 2014 |
| 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer W Cytawa, AK Seitz, S Kircher, K Fukushima, J Tran-Gia, A Schirbel, ... European journal of nuclear medicine and molecular imaging 47, 168-177, 2020 | 86 | 2020 |
| Anti-angiogenesis and immunotherapy: novel paradigms to envision tailored approaches in renal cell-carcinoma A Argentiero, AG Solimando, M Krebs, P Leone, N Susca, O Brunetti, ... Journal of Clinical Medicine 9 (5), 1594, 2020 | 59 | 2020 |
| Second-line treatments for advanced hepatocellular carcinoma: A systematic review and bayesian network meta-analysis AG Solimando, N Susca, A Argentiero, O Brunetti, P Leone, V De Re, ... Clinical and Experimental Medicine 22 (1), 65-74, 2022 | 56 | 2022 |
| miR-221-3p regulates VEGFR2 expression in high-risk prostate cancer and represents an escape mechanism from sunitinib in vitro M Krebs, AG Solimando, C Kalogirou, A Marquardt, T Frank, I Sokolakis, ... Journal of Clinical Medicine 9 (3), 670, 2020 | 56 | 2020 |
| miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo M Kiener, L Chen, M Krebs, J Grosjean, I Klima, C Kalogirou, H Riedmiller, ... BMC cancer 19, 1-17, 2019 | 55 | 2019 |
| MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer C Kalogirou, M Spahn, M Krebs, S Joniau, E Lerut, M Burger, CJ Scholz, ... International journal of molecular sciences 14 (11), 21414-21434, 2013 | 55 | 2013 |
| MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer C Kalogirou, J Linxweiler, P Schmucker, MT Snaebjornsson, W Schmitz, ... Nature communications 12 (1), 5066, 2021 | 53 | 2021 |
| Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava DC Vergho, S Kneitz, C Kalogirou, M Burger, M Krebs, A Rosenwald, ... PloS one 9 (10), e109877, 2014 | 41 | 2014 |
| Subgroup-independent mapping of renal cell carcinoma—machine learning reveals prognostic mitochondrial gene signature beyond histopathologic boundaries A Marquardt, AG Solimando, A Kerscher, M Bittrich, C Kalogirou, H Kübler, ... Frontiers in oncology 11, 621278, 2021 | 37 | 2021 |
| Metformin-derived growth inhibition in renal cell carcinoma depends on miR-21-mediated PTEN expression C Kalogirou, D Schäfer, M Krebs, F Kurz, A Schneider, H Riedmiller, ... Urologia internationalis 96 (1), 106-115, 2016 | 37 | 2016 |
| The role of magnetic resonance imaging in the diagnosis of penile fracture in real-life emergency settings: comparative analysis with intraoperative findings I Sokolakis, T Schubert, M Oelschlaeger, M Krebs, JE Gschwend, ... The Journal of Urology 202 (3), 552-557, 2019 | 35 | 2019 |
| Long-term outcome of nephron-sparing surgery compared to radical nephrectomy for renal cell carcinoma≥ 4 cm-a matched-pair single institution analysis C Kalogirou, H Fender, P Muck, V Hey, M Krebs, H Riedmiller, D Vergho Urologia internationalis 98 (2), 138-147, 2017 | 21 | 2017 |
| Metabolic tumour volume from PSMA PET/CT scans of prostate cancer patients during chemotherapy—do different software solutions deliver comparable results? PE Hartrampf, M Heinrich, AK Seitz, J Brumberg, I Sokolakis, C Kalogirou, ... Journal of Clinical Medicine 9 (5), 1390, 2020 | 20 | 2020 |
| Preoperative C-reactive protein values as a potential component in outcome prediction models of metastasized renal cell carcinoma patients receiving cytoreductive nephrectomy C Kalogirou, P Mulfinger, I Sokolakis, M Krebs, H Kübler, H Riedmiller, ... Urologia Internationalis 99 (3), 297-307, 2017 | 18 | 2017 |
| miR‐221 Augments TRAIL‐Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1 M Krebs, C Behrmann, C Kalogirou, I Sokolakis, S Kneitz, ... BioMed research international 2019 (1), 6392748, 2019 | 14 | 2019 |
| Wie soll die Hormontherapie beim kastrationsresistenten Prostatakarzinom fortgefuhrt werden? M Spahn, M Krebs Der Urologe. Ausg. A. 51 (1), 15, 2012 | 14 | 2012 |
| Angiogenesis as therapeutic target in metastatic prostate cancer–narrowing the gap between bench and bedside AG Solimando, C Kalogirou, M Krebs Frontiers in Immunology 13, 842038, 2022 | 13 | 2022 |
